首页> 外文OA文献 >FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

【2h】

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

机译：一线5-氟尿嘧啶/亚叶酸和奥沙利铂+/-西妥昔单抗治疗转移性结直肠癌患者的FCGR2A和FCGR3A基因多态性与临床结局

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

机译：-

著录项

作者
Kjersem Janne Beathe; Skovlund Eva; Ikdahl Tone; Guren Tormod Kyrre; Kersten Christian; Dalsgaard Astrid Marie; Yilmaz Mette Karen; Fokstuen Tone; Tveit Magne Kjell; Kure Elin H.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab [J] . Janne B Kjersem, Eva Skovlund, Tone Ikdahl, BMC Cancer . 2014,第1期

机译：一线5-氟尿嘧啶/亚叶酸和奥沙利铂+/-西妥昔单抗治疗转移性结直肠癌患者的FCGR2A和FCGR3A基因多态性及临床结局
2. FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab. [J] . Zhang W, Gordon M, Schultheis AM, Journal of Clinical Oncology . 2007,第24期

机译：FCGR2A和FCGR3A多态性与单药西妥昔单抗治疗的表皮生长因子受体表达转移性结直肠癌患者的临床结局相关。
3. Let-7 miRNA-binding site polymorphism in the KRAS 3 ′ UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/? cetuximab [J] . Janne B Kjersem, Tone Ikdahl, Tormod Guren, BMC Cancer . 2012,第1期

机译：KRAS 3'UTR中的let-7 miRNA结合位点多态性; 5-氟尿嘧啶和奥沙利铂+ /？治疗转移性结直肠癌患者的结直肠癌筛查人群患病率及其对临床结局的影响西妥昔单抗
4. PIK3CA Pathway and CTNNB1 Determine Poor Response of Cetuximab in Right-Sided Metastatic Colorectal Cancer [C] . Pi-Yueh Chang International Molecular Medicine Tri-Conference. . 2019

机译：Pik3CA途径和CTNNB1确定右侧转移性结肠直肠癌中西妥昔单抗的良差
5. Clinical and Economic Outcomes for Gastric Cancer Patients Treated with Gastrectomy at Centres with and without Cancer Surgery Designation in Ontario [D] . Jeong, Yunni . 2019

机译：安大略省患有癌症手术指定胃癌治疗胃癌患者的胃癌患者的临床和经济结果
6. FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab [O] . Janne B Kjersem, Eva Skovlund, Tone Ikdahl, 2014

机译：一线5-氟尿嘧啶/亚叶酸和奥沙利铂+/-西妥昔单抗治疗转移性结直肠癌患者的FCGR2A和FCGR3A基因多态性与临床结局
7. FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab [O] . Kjersem, Janne B, Skovlund, Eva, Ikdahl, Tone, 2014

机译：用一线5-氟尿嘧啶/亚叶酸和奥沙利铂+/-西妥昔单抗治疗转移性结直肠癌患者的FCGR2a和FCGR3a多态性及临床转归

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

摘要

著录项

相似文献

相关主题

期刊订阅